These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15711939)

  • 1. TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation.
    Puduvalli VK; Sampath D; Bruner JM; Nangia J; Xu R; Kyritsis AP
    Apoptosis; 2005 Jan; 10(1):233-43. PubMed ID: 15711939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
    Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
    Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway.
    Kim KM; Lee YJ
    Oncogene; 2005 Jan; 24(3):355-66. PubMed ID: 15558024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells.
    Okhrimenko H; Lu W; Xiang C; Hamburger N; Kazimirsky G; Brodie C
    Cancer Res; 2005 Aug; 65(16):7301-9. PubMed ID: 16103081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis.
    Dubská L; Andera L; Sheard MA
    FEBS Lett; 2005 Aug; 579(19):4149-58. PubMed ID: 16023111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release.
    Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB
    Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R; Bedi A
    Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2.
    Alladina SJ; Song JH; Davidge ST; Hao C; Easton AS
    J Vasc Res; 2005; 42(4):337-47. PubMed ID: 15985761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
    Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G
    Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
    Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC
    Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.
    Song JH; Song DK; Pyrzynska B; Petruk KC; Van Meir EG; Hao C
    Brain Pathol; 2003 Oct; 13(4):539-53. PubMed ID: 14655759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation.
    Cho YL; Lee KS; Lee SJ; Namkoong S; Kim YM; Lee H; Ha KS; Han JA; Kwon YG; Kim YM
    Biochem Biophys Res Commun; 2005 Jan; 326(4):752-8. PubMed ID: 15607733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG; Murillo CA; Evers BM
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
    Oka N; Nakahara S; Takenaka Y; Fukumori T; Hogan V; Kanayama HO; Yanagawa T; Raz A
    Cancer Res; 2005 Sep; 65(17):7546-53. PubMed ID: 16140916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage.
    Bild AH; Mendoza FJ; Gibson EM; Huang M; Villanueva J; Garrington TP; Jove R; Johnson GL; Gibson SB
    Oncogene; 2002 Sep; 21(43):6649-56. PubMed ID: 12242663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
    Nakshatri H; Rice SE; Bhat-Nakshatri P
    Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZD1839 (Gefitinib, 'Iressa'), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma.
    Teraishi F; Kagawa S; Watanabe T; Tango Y; Kawashima T; Umeoka T; Nisizaki M; Tanaka N; Fujiwara T
    FEBS Lett; 2005 Aug; 579(19):4069-75. PubMed ID: 16023108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway.
    Nam SY; Amoscato AA; Lee YJ
    Oncogene; 2002 Jan; 21(3):337-46. PubMed ID: 11821946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.